DiaMedica Therapeutics (DMAC)
(Delayed Data from NSDQ)
$3.12 USD
-0.13 (-4.00%)
Updated May 10, 2024 03:59 PM ET
After-Market: $3.12 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.16 | 0.00% |
Earnings Summary
For their last quarter, DiaMedica Therapeutics (DMAC) reported earnings of -$0.14 per share, beating the Zacks Consensus Estimate of $-0.16 per share. This reflects a positive earnings surprise of 12.50%. Look out for DMAC's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.16 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for DMAC
DiaMedica Therapeutics (DMAC) Loses -19.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
DMAC: What are Zacks experts saying now?
Zacks Private Portfolio Services